Form 4 for DGX Quest Diagnostics
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001022079-25-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-04 | DGX | Doherty Catherine T. | EVP, Regional Businesses | A - Grant | $173.74 | +10.4K | 78.4K | +15% | +$1.80M | |
| 2025-03-05 | 2025-03-04 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $175.79 | -716 | 68.1K | -1% | -$125.9K | |
| M | 2025-03-05 | 2025-03-03+ | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $173.74 | -5,404 | 68.8K | -7% | -$938.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | A | A | 10,380 | $173.74 | 78,448 | D | — | — | (F3) Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award approved in accordance with the requirements of Rule 16b-3(d). |
| 2 | Common | Common Stock | 2025-03-04 | S | D | 716 | $175.79 | 68,068 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-04 | F | D | 5,010 | $173.74 | 73,438 | D | — | — | (F4) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. |
| 4 | Common | Common Stock | 2025-03-03 | F | D | 394 | $173.74 | 68,784 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |